I agree that this site is using cookies. You can find further informations here.
X
Pons‐Tostivint, Elvire
61  results:
Search for persons X
?
1

Interplay between oncolytic measles virus, macrophages and ..:

Chatelain, Camille ; Berland, Laurine ; Grard, Marion...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

Biomarker and pharmacodynamic activity of the transforming ..:

Robbrecht, Debbie ; Grob, Jean‐Jacques ; Bechter, Oliver...
Clinical and Translational Science.  17 (2024)  2 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
3

Biomarker-directed targeted therapy plus durvalumab in adva..:

Besse, Benjamin ; Pons-Tostivint, Elvire ; Park, Keunchil...
Nature Medicine.  30 (2024)  3 - p. 716-729 , 2024
Link: https://doi.org/10.1038/..
 
?
4

Enquête nationale auprès des infirmiers en pratique avancée..:

Pons-Tostivint, Elvire ; De Decker, Laure ; Haudebert, Gaëlle...
Bulletin du Cancer.  111 (2024)  6 - p. 566-575 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Use of non-small cell lung cancer multicellular tumor spher..:

Hulo, Pauline ; Deshayes, Sophie ; Fresquet, Judith...
Respiratory Research.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Concomitant ALK translocation and EGFR C797S mutation as re..:

Pons-Tostivint, Elvire ; Hulo, Pauline ; Sagan, Christine...
Respiratory Medicine and Research.  86 (2024)  - p. 101116 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Prognostic Impact of TP53 Mutations in Metastatic Nonsquamo..:

Mathiot, Laurent ; Nigen, Benoit ; Goronflot, Thomas...
Clinical Lung Cancer.  25 (2024)  3 - p. 244-253.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
8

A Multicenter Study Assessing the Real-World Use and Effect..:

Porte, Marie ; Vaudron, Adrien ; Crequit, Perrine...
Clinical Lung Cancer.  25 (2024)  2 - p. e101-e111.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Impact of PD-L1 Expression on the Overall Survival of Cauca..:

Papazyan, Thomas ; Denis, Marc G. ; Sagan, Christine...
Targeted Oncology.  19 (2024)  4 - p. 611-621 , 2024
Link: https://doi.org/10.1007/..
 
?
10

Second-line treatment outcomes after first-line chemotherap..:

Pons-Tostivint, Elvire ; Ezzedine, Remy ; Goronflot, Thomas...
Lung Cancer.  194 (2024)  - p. 107887 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Impact of first-line immunotherapy on survival and intracra..:

Nigen, Benoit ; Goronflot, Thomas ; Herbreteau, Guillaume...
Lung Cancer.  184 (2023)  - p. 107321 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Trastuzumab Deruxtecan in Patients with HER2-Mutant Metasta..:

Goto, Koichi ; Goto, Yasushi ; Kubo, Toshio...
Journal of Clinical Oncology, Vol.41 No.31, pp.4852-4863.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metasta..:

Goto, Koichi ; Goto, Yasushi ; Kubo, Toshio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617843/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Molecular minimal residual disease in resected non-small ce..:

Denis, Marc ; Herbreteau, Guillaume ; Pons-Tostivint, Elvire
info:eu-repo/semantics/altIdentifier/doi/10.21037/tlcr-22-899.  , 2023
Link: https://www.hal.inserm.f..
 
?
15

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metasta..:

Goto, Koichi ; Goto, Yasushi ; Kubo, Toshio...
info:eu-repo/semantics/altIdentifier/pmid/37694347.  , 2023
Link: https://hdl.handle.net/2..
 
1-15